Viewing Study NCT00416351

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-06-25 @ 3:44 AM
Study NCT ID: NCT00416351
Status: COMPLETED
Last Update Posted: 2022-05-17
First Post: 2006-12-27
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
None Small Intestine Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None anaplastic large cell lymphoma View
None angioimmunoblastic T-cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult T-cell leukemia/lymphoma View
None recurrent mycosis fungoides/Sezary syndrome View
None adult nasal type extranodal NK/T-cell lymphoma View
None prolymphocytic leukemia View
None childhood nasal type extranodal NK/T-cell lymphoma View
None recurrent childhood lymphoblastic lymphoma View
None recurrent cutaneous T-cell non-Hodgkin lymphoma View
None small intestine lymphoma View